Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

"Questionable results" yielded by feline diabetes research
cat
Dr Niessen says human-style clinical trials are needed to compare the effectiveness of different treatments.
RVC's systematic review finds more collaboration and larger sample sizes are needed

Past research on feline diabetes lacks collaboration and is based on low-level evidence, leading to "questionable results". This is according to a systematic review of research papers carried out by the Royal Veterinary College (RVC).

"Current research into the condition is sporadic, lacking a long-term vision and not collaborative," says Dr Stijn Niessan, who launched the RVC's Feline Diabetic Remission Clinic (FDRC) with his team in 2013.

Dr Niessan believes human-style clinical trials are the best method to compare remission rates with different types of insulin.

"The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.

“This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits."

Researchers say treatment recommendations are based on past research with sample sizes of as few as eight cat and the largest samples contained 50 to 60 cats. Statistical tests carried out by the FDRC team suggest that a minimum of 80 to 90 cats are required to accurately compare different treatments.

Dr Niessan says more collaboration is needed both nationally and internationally to address the inconsistencies in the treatment of feline diabetes.

"A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition," he explains. "The owner could then go online and find a third way. These treatments aren’t necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way.

"This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com